Monthly Archives June 2017

The following product(s) are being reference priced from 1 August 2017, which comes about from an alternative being award the Sole Supply within the next few months. We are highlighting these so that you have time to manage the transition. With price support from the suppliers ProPharma / PWR will be reducing the pricing to match the new subsidy from…

New listing in both the Pharmaceutical Schedule Section B and Section H (HML) from 1 July 2017. Flucil Injection 1 g vial 5 pack. Reference pricing will apply to Flucloxin Inj 1 g 10 from 1 September 2017 with delisting from HML 1 1 September 2017 and Pharmaceutical Schedule 1 December 2017. Further information is provided on our website under…

We have been advised by AFT that they will only partially supplying our orders from today of Prednisolone Eye Drops 10mg/ml 10ml Dropper  AFT - Pharmacode 2501511, due to supply issues. Naturally we need to ensure the market does not panic buy or stock pile and have implemented an allocation of 10 per customer per week. This allocation will be…

Boucher and Muir (Concordia) have alerted us to a supply issue for its brand of levothyroxine 100mcg (Pharmacode 2307758). Briefly, they have exhausted their stock, with new stock due to arrive on Sunday 25 June. Allowing several days for customs and shipping, stock may not be available until late next week. Providing we do not stock piling or panic buy…

On behalf of pharmacy we would like express thanks to Multichem for their initiative in reducing the price of the above product effective 17 June 2017. Pharmacy can now purchase at manufacturer cost of $1.95 improving the margin on this product effectively by $0.60 per unit until reference pricing is applied 1 October 2017. This allows pharmacy to continue to…

On behalf of pharmacy we would like to thank Douglas Pharmaceuticals Ltd for their initiative in reducing the price of Bosvate Tab 2.5 ,g 30,  Bosvate Tab 5 mg 30 and Bosvate Tab 10 mg 30 to reference pricing level effective from 13th June 2017. This change will occur in the Pharmaceutical Schedule effective 1 August 2017. This is significant…

Click here to read PHARMAC DISPATCH of 6th June 2017. Subject: Metoprolol Succinate. We ask you all to please be patient for a little longer as we work through this last transition for metoprolol succinate. It certainly has tested everyone’s patience over the last 18 months or so. Now more than ever we will need to manage stock through the…

The following products are being reference priced from 1 July 2017, which comes about from an alternative being award the Sole Supply  within the next few months. We are highlighting these so that you have time to manage the transition. With price support from the suppliers ProPharma / PWR will be reducing the pricing to match the new subsidy from…

New listing in both the Pharmaceutical Schedule Section B and Section H (HML) from 1 October 2017. Escitalopram-Apo Tab 10 mg and 20 mg 28 tablet blister packs. Reference pricing will apply from 1 December 2017 with delisting from HML 1 December 2017 and Pharmaceutical Schedule 1 March 2018. Further information is provided on our website under Pharmac Changes. As…

12
Close